scispace - formally typeset
Z

Zhikui Liu

Researcher at Xi'an Jiaotong University

Publications -  68
Citations -  2688

Zhikui Liu is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: microRNA & Protein kinase B. The author has an hindex of 25, co-authored 53 publications receiving 1905 citations. Previous affiliations of Zhikui Liu include Mayo Clinic.

Papers
More filters
Journal ArticleDOI

Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.

TL;DR: Clinically, CASC2 underexpression and miR-367 overexpression were closely correlated with the metastasis-associated clinicopathologic features and it is concluded that the CASC 2/miR- 367/FBXW7 axis may be a ponderable and promising therapeutic target for HCC.
Journal ArticleDOI

HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma

TL;DR: HSP90 potentiates the glycolysis and proliferation, reduces the apoptosis and thus enhances the growth of HCC cells through PKM2, and a combination of these proteins could strongly predict the poor prognosis of H CC patients.
Journal ArticleDOI

P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.

TL;DR: Liver stiffness to activate HSC differentiation into myofibroblasts, which required nuclear accumulation of p300, and RNA sequencing and chromatin immunoprecipitation-quantitative polymerase chain reaction were used to identify HSC genes that changed expression levels in response to stiffness.
Journal ArticleDOI

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.

TL;DR: It was found that the expression of miR-1296 was reduced in HCC tissues and cell lines, and it was associated with metastasis and recurrence of HCC, and the promoting effects of hypoxia on metastasis-to-mesenchymal transition (EMT) and EMT of H CC cells were reversed by miR -1296.
Journal ArticleDOI

Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis

TL;DR: In HSCs, autophagy inhibits fibrogenic EV release which can attenuate liver fibrosis, and an mTOR (mammalian target of rapamycin) signaling molecule to be regulated by SHP2 and PDGF is identified.